Latest
1752vc1752vc|Deviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech StartupsDeviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech Startups|ParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology TherapiesParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology Therapies|DISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer RetentionDISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer Retention|a16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructurea16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructure|Restive Ventures Raises $45M Fund III to Back AI-Native Financial Services StartupsRestive Ventures Raises $45M Fund III to Back AI-Native Financial Services Startups|5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services|Pit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise OperationsPit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise Operations|Lunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure SystemsLunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure Systems|Anagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic FibrosisAnagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic Fibrosis|1752vc1752vc|Deviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech StartupsDeviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech Startups|ParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology TherapiesParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology Therapies|DISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer RetentionDISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer Retention|a16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructurea16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructure|Restive Ventures Raises $45M Fund III to Back AI-Native Financial Services StartupsRestive Ventures Raises $45M Fund III to Back AI-Native Financial Services Startups|5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services|Pit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise OperationsPit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise Operations|Lunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure SystemsLunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure Systems|Anagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic FibrosisAnagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic Fibrosis
Back to articles

First Round Capital

Most firms wait for traction to speak, but First Round Capital built its edge listening before the noise, deep inside the earliest layer of the startup ecosystem, where conviction shows up long before proof. Founded in 2004 by Josh Kopelman, who sold Half.com to eBay, and Howard Morgan, who helped build Renaissance Technologies and Idealab, the firm chose a harder game. They leaned into uncertainty while others waited for signal. By 2009, Bloomberg called them the most active seed investor in the country, not because they chased volume, but because they understood that the first check often shapes the entire outcome.

Inside the firm, the pattern is consistent. Josh Kopelman operates alongside Bill Trenchard, Brett Berson, Todd Jackson, Hayley Barna, and Liz Wessel, a group built less like financiers and more like former operators who remember what it feels like when payroll is a question. The typical check lands between $1M–$10M, often pre-revenue, sometimes pre-product, always anchored in a single idea: the founder sees something others do not. They call it a compelling insight, and it is less about charisma and more about clarity, the ability to articulate a truth that bends the room just enough to make belief possible.

The outcomes read like a timeline of the modern startup ecosystem. Uber when it was still friction. Square when skepticism was written into the pitch. Notion after multiple rebuilds. Roblox before scale made it obvious. Looker before Google stepped in with $2.6B. Flatiron Health before Roche closed at $1.9B. Then the newer wave with Verkada, K2 Space, and Pomelo Care, stretching across security, space, and healthcare with the same underlying signal. Different categories, same founder trait. Obsession that does not negotiate.

What sharpens First Round Capital is not just entry point, it is proximity. The firm built infrastructure around the earliest phase, where most companies fail quietly. Talent, go to market, and the First Round Review are not accessories, they are extensions of the investment itself. Insights are documented, shared, and pressure-tested across a network that behaves like a living system. The data reinforces the thesis. Diverse founding teams outperform by 63%. Geography does not dictate outcomes. The startup ecosystem rewards insight, not proximity, and First Round Capital has spent two decades operationalizing that belief.

If you are building and the idea still feels slightly uncomfortable to explain, that tension might be the signal. And if you are looking to step into a company before the narrative hardens, their portfolio is hiring across AI, enterprise, healthcare, fintech, and beyond. The startup ecosystem does not wait for permission, and neither do the teams inside it.

Follow this firm. Study their founders. Track their plays.